| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders +1 more
GALWAY, Ireland, October 15, 2026 – Medtronic plc (Medtronic; NYSE: MDT) today announced the completion of its separation of MiniMed Group, Inc. (MiniMed; Nasdaq: MMED). |
| 17 Sep 2026 |
8-K: Other Events
On September 14, 2026, Medtronic plc, a public limited company organized under the laws of Ireland (“Medtronic”), commenced an offer to exchange (the “Exchange Offer”) up to 225,361,295 newly issued shares of common stock, par value $0.0... |
| 01 Sep 2026 |
8-K: Results of Operations and Financial Condition
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance |
| 03 Jun 2026 |
8-K: Results of Operations and Financial Condition
Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years |
| 18 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
| 27 Apr 2026 |
8-K: Regulation FD Disclosure
Medtronic has determined that an unauthorized party accessed data in certain Medtronic corporate IT systems. |
| 24 Mar 2026 |
8-K: Regulation FD Disclosure
On March 18, 2026, MiniMed Group, Inc. (MiniMed), a consolidated subsidiary of Medtronic plc (Company) announced that the U.S. Food and Drug Administration (FDA) has cleared the MiniMed Flex™, a next-generation discreet, smartphone-contr... |
| 17 Feb 2026 |
8-K: Results of Operations and Financial Condition
fiscal 2026 results with highest enterprise revenue growth in 10 quarters |
| 18 Nov 2025 |
8-K: Results of Operations and Financial Condition
fiscal 2026 financial results, enterprise growth drivers accelerate momentum |
| 03 Nov 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 21 Oct 2025 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
1.The name of the Company is: Medtronic public limited company. |
| 29 Sep 2025 |
8-K: Entry into a Material Definitive Agreement; Other Events
SIXTH SUPPLEMENTAL INDENTURE, dated as of September 29, 2025 (the “Sixth Supplemental Indenture”), to the Indenture dated as of December 10, 2014 (the “Base Indenture”), between Medtronic, Inc., a Minnesota corporation (the “Company”), a... |
| 16 Sep 2025 |
8-K: Regulation FD Disclosure; Other Events
Medtronic, Inc., a Minnesota corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule I hereto (the “Underwriters”), for whom Deutsche Bank AG, London Branch and Goldman Sachs & Co. LLC are a... |
| 19 Aug 2025 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
GALWAY, Ireland – August 19, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025. |
| 23 Jun 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
GALWAY, Ireland – June 23, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent dire... |
| 21 May 2025 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; |
| 17 Mar 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 18 Feb 2025 |
8-K: Results of Operations and Financial Condition
Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation |
| 21 Jan 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Medtronic appoints Thierry Piéton as Chief Financial Officer |
| 19 Nov 2024 |
8-K: Results of Operations and Financial Condition
Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation |
Loading...